Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.
about
Chemokines and chemokine receptors: update on utility and challenges for the clinician.Plasmodium falciparum proteins involved in cytoadherence of infected erythrocytes to chemokine CX3CL1CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan InteractionsTargeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug designFragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction.Structural analysis of a novel small molecule ligand bound to the CXCL12 chemokine.Glycosaminoglycan analogs as a novel anti-inflammatory strategyPeptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1.An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in miceDevelopment of anticancer drugs based on the hallmarks of tumor cells.Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo.C-Geranylated flavonoids from Paulownia tomentosa fruits with antimicrobial potential and synergistic activity with antibiotics.Potential combinatorial effects of recombinant atypical chemokine receptors in breast cancer cell invasion: A research perspective.
P2860
Q27687402-908621EC-96F0-4C6A-A311-B0B7E9ADE6CFQ30042320-C01F1299-7CDC-4BF9-AF2E-089FA0AAD790Q30848125-010190E8-E69A-4B23-8B5D-A97E2182BF19Q33574702-1E776CE0-F4D3-4A31-B7D6-BBA3C4D71721Q34569177-1EBD6192-6460-4539-A137-E387A9296361Q34631525-B5D560C5-9D20-490D-B5F6-82DE11E44C38Q36321143-E210F4C2-91A3-4782-AA82-9C4E5BF5769EQ36392735-93AF1CF9-EFE1-4FA8-8843-1E579C69955DQ36796828-F5B919C2-2E8F-4F06-A184-5FFA34CD1A5EQ38182491-BC798119-02E5-4F98-97F9-1912BD0C27CFQ39736612-CA3EDDAD-62EC-4ABC-827C-B6444A64D7FCQ40825460-7E875EB9-6BB7-472F-BBAA-5EEEF6AE3175Q42568212-EECE061E-5899-42A2-BE7D-A77175AAE307
P2860
Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neutralizing endogenous chemok ...... tial therapeutic applications.
@en
Neutralizing endogenous chemok ...... tial therapeutic applications.
@nl
type
label
Neutralizing endogenous chemok ...... tial therapeutic applications.
@en
Neutralizing endogenous chemok ...... tial therapeutic applications.
@nl
prefLabel
Neutralizing endogenous chemok ...... tial therapeutic applications.
@en
Neutralizing endogenous chemok ...... tial therapeutic applications.
@nl
P2093
P1476
Neutralizing endogenous chemok ...... ntial therapeutic applications
@en
P2093
Francois Daubeuf
Jacques Haiech
Jean-Luc Galzi
Marcel Hibert
Muriel Hachet-Haas
Nelly Frossard
Sandra Lecat
P356
10.1016/J.PHARMTHERA.2009.12.003
P577
2010-02-01T00:00:00Z